Evidence map›Paper›PMID 39265915›Full record

ArticleJournal of substance use and addiction treatment2024

Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.

Riley Shearer, Hildi Hagedorn, Honora Englander, Tracy Siegler, Roxanne Kibben, Adetayo Fawole, Alisa Patten, Amy Fitzpatrick, JoAn Laes, Jasmine Fernando and 11 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04921787 (Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Implementation Trial of High Intensity Versus Low Intensity Strategy for Supporting Hospital-Based Opioid Use Disorder Treatment), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04921787 naactive not recruitingnot on this map

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Implementation Trial of High Intensity Versus Low Intensity Strategy for Supporting Hospital-Based Opioid Use Disorder Treatment

TypeinterventionalSponsorGavin BartRan2021 to 2026Enrolled24ConditionsSubstance Use Disorders, Opioid Use Disorder, Severe, Opioid Use Disorder, ModerateArmsLow Intensity, High Intensity
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Riley ShearerUniversity of Minnesota School of Public Health, Minneapolis, MN 55407, USA.
Hildi HagedornMinneapolis Veterans Affairs Health Care System, Minneapolis, MN 55417, USA.
Honora EnglanderOregon Health and Science University, Portland, OR 97239, USA.
Tracy SieglerUniversity of Wisconsin, Madison, WI 53706, USA.
Roxanne KibbenHennepin Healthcare Research Institute, Minneapolis, MN 55415, USA.
Adetayo FawoleNew York University Grossman School of Medicine, New York, NY 10016, USA.
Alisa PattenOregon Health and Science University, Portland, OR 97239, USA.
Amy FitzpatrickBoston Medical Center and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
JoAn LaesHennepin Healthcare Research Institute, Minneapolis, MN 55415, USA.
Jasmine FernandoNew York University Grossman School of Medicine, New York, NY 10016, USA.
Noa AppletonNew York University Grossman School of Medicine, New York, NY 10016, USA.
Emily OotBoston University, Boston, MA 02215, USA.
Hope TitusOregon Health and Science University, Portland, OR 97239, USA.
Noa KrawczykNew York University Grossman School of Medicine, New York, NY 10016, USA.
Zoe WeinsteinBoston Medical Center and the Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Jennifer McNeelyNew York University Grossman School of Medicine, New York, NY 10016, USA.
Paulette BaukolHennepin Healthcare Research Institute, Minneapolis, MN 55415, USA.
Udi GhitzaNational Institute on Drug Abuse, North Bethesda, MD 20852, USA.
Dave GustafsonUniversity of Wisconsin, Madison, WI 53706, USA.
Gavin BartHennepin Healthcare, Minneapolis, MN 55415, USA.
Angela BazziUniversity of California San Diego, La Jolla, CA 92093, USA. Electronic address: abazzi@health.ucsd.edu.

Funding

Suicide Prediction and Prevention for People at Risk for Opioid Use DisorderUG1DA040316 · NIDA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI GAVIN BART · 2015 to 2026
$42.2M
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS75N95024D00012 · NIDA · MIDWEST RESEARCH INSTITUTE · PI SLADE, DESMOND · 2024 to 2025
$742k
Beyond Treatment Initiation: Enhancing Opioid Use Disorder Care Transitions Across Health System TouchpointsK01DA055758 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Noa Krawczyk · 2023 to 2026
$722k
Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-useF30DA057775 · NIDA · UNIVERSITY OF MINNESOTA · PI Riley Shearer · 2023 to 2026
$171k
SCIENTIFIC, OPERATIONS, AND ADMINISTRATIVE RESOURCES (SOAR) TO NIH.75N95021D00012 · NIDA · KELLY SERVICES, INC. · PI SPROSE, SARA · 2021 to 2021
$57k
CLC NIH HHS 75N90019D00013NIDA NIH HHS 75N95021D00012NIDA NIH HHS 75N95021D00013NIDA NIH HHS 75N95024D00012NIDA NIH HHS F30 DA057775NIDA NIH HHS K01 DA055758NIDA NIH HHS UG1 DA040316NIEHS NIH HHS 75N96020D00012ORFDO NIH HHS 75N99019D00013ORFDO NIH HHS 75N99020D00012
6 · The paper itself

Abstract

introductionMethadone and buprenorphine are effective treatment for opioid use disorder (OUD), yet they are vastly under-utilized across US hospitals. To inform a national trial assessing the effectiveness of implementation strategies to increase adoption of an inpatient hospital-based opioid treatment (HBOT) model (NCT04921787), we explored barriers and facilitators to expanding medication for opioid use disorder (MOUD) within community hospitals across the United States.

methodsFrom November 2021 to March 2022, we used purposeful and snowball sampling to identify and interview participants involved in inpatient care of patients with OUD from twelve community hospitals. We conducted semi-structured interviews on providers' experiences and perspectives on current treatment approaches as well as potential influences on MOUD expansion in their hospitals. We used thematic analysis to identify key barriers and facilitators that could impact implementation of an HBOT model, and organized these findings based on the Consolidated Framework for Implementation Research (CFIR).

resultsFrom qualitative interviews with 57 participants (30 physicians, 7 pharmacists, 6 nurses, and 14 professionals involved in the care of patients with OUD), we identified key barriers and facilitators mapped to CFIR's internal and outer settings. The most salient inner setting domains included tension for change and relative priority, compatibility, available resources, organizational culture, access to knowledge and information, relational connections and communications, and information technology infrastructure. Outer setting domains included policies and laws, financing, and partnerships and connections.

conclusionsIdentifying potential barriers and facilitators can inform hospital-specific strategies to support implementation of HBOT. Implementation strategies that address barriers such as staff availability, knowledge, and attitudes may support increased HBOT adoption. On a broader scale, national policy changes such as increased financing and public reporting of quality metrics would address other barriers we identified and may also encourage hospitals to adopt HBOT models.

Indexed as

BuprenorphineHospitals, CommunityOpiate Substitution TreatmentOpioid-Related DisordersAnalgesics, OpioidAttitude of Health PersonnelFemaleHumansInterviews as TopicMaleMethadoneMulticenter Studies as TopicQualitative ResearchRandomized Controlled Trials as TopicUnited StatesAnalgesics, OpioidBuprenorphineMethadoneConsolidated framework for implementation researchHospital addiction servicesImplementation scienceMedication for opioid use disorder

Identifiers

PMID39265915
PMCPMC11749276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.